These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25004863)

  • 1. Podocalyxin is a marker of poor prognosis in colorectal cancer.
    Kaprio T; Fermér C; Hagström J; Mustonen H; Böckelman C; Nilsson O; Haglund C
    BMC Cancer; 2014 Jul; 14():493. PubMed ID: 25004863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.
    Larsson A; Johansson ME; Wangefjord S; Gaber A; Nodin B; Kucharzewska P; Welinder C; Belting M; Eberhard J; Johnsson A; Uhlén M; Jirström K
    Br J Cancer; 2011 Aug; 105(5):666-72. PubMed ID: 21829192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer.
    Larsson A; Fridberg M; Gaber A; Nodin B; Levéen P; Jönsson G; Uhlén M; Birgisson H; Jirström K
    BMC Cancer; 2012 Jul; 12():282. PubMed ID: 22769594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of two PODXL antibodies in 840 colorectal cancer patients.
    Kaprio T; Hagström J; Fermér C; Mustonen H; Böckelman C; Nilsson O; Haglund C
    BMC Cancer; 2014 Jul; 14():494. PubMed ID: 25004935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer.
    Larsson AH; Lehn S; Wangefjord S; Karnevi E; Kuteeva E; Sundström M; Nodin B; Uhlén M; Eberhard J; Birgisson H; Jirström K
    J Transl Med; 2016 May; 14(1):128. PubMed ID: 27160084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.
    Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Fermér C; Nilsson O; Seppänen H; Haglund C
    PLoS One; 2015; 10(6):e0129012. PubMed ID: 26053486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocalyxin as a Prognostic Marker in Gastric Cancer.
    Laitinen A; Böckelman C; Hagström J; Kokkola A; Fermér C; Nilsson O; Haglund C
    PLoS One; 2015; 10(12):e0145079. PubMed ID: 26674770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma.
    Heby M; Elebro J; Nodin B; Jirström K; Eberhard J
    BMC Clin Pathol; 2015; 15():10. PubMed ID: 26028992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases.
    Larsson AH; Nodin B; Syk I; Palmquist I; Uhlén M; Eberhard J; Jirström K
    Diagn Pathol; 2013 Jul; 8():109. PubMed ID: 23819542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.
    Boman K; Andersson G; Wennersten C; Nodin B; Ahlgren G; Jirström K
    Biomark Res; 2017; 5():10. PubMed ID: 28293425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of LEA, a podocalyxin-like glycoprotein, as a predictor for the progression of colorectal cancer.
    Yuan D; Chen H; Wang S; Liu F; Cheng Y; Fang J
    Cancer Med; 2018 Oct; 7(10):5155-5166. PubMed ID: 30277651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.
    Boman K; Larsson AH; Segersten U; Kuteeva E; Johannesson H; Nodin B; Eberhard J; Uhlén M; Malmström PU; Jirström K
    Br J Cancer; 2013 Jun; 108(11):2321-8. PubMed ID: 23652315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma.
    Borg D; Larsson AH; Hedner C; Nodin B; Johnsson A; Jirström K
    J Transl Med; 2018 Oct; 16(1):290. PubMed ID: 30355278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
    Li P; Xiao Z; Braciak TA; Ou Q; Chen G; Oduncu FS
    PLoS One; 2017; 12(3):e0172799. PubMed ID: 28253296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PODXL, negatively regulated by KLF4, promotes the EMT and metastasis and serves as a novel prognostic indicator of gastric cancer.
    Zhang J; Zhu Z; Wu H; Yu Z; Rong Z; Luo Z; Xu Y; Huang K; Qiu Z; Huang C
    Gastric Cancer; 2019 Jan; 22(1):48-59. PubMed ID: 29748877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PODXL might be a new prognostic biomarker in various cancers: a meta-analysis and sequential verification with TCGA datasets.
    He S; Du W; Li M; Yan M; Zheng F
    BMC Cancer; 2020 Jul; 20(1):620. PubMed ID: 32615943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-Induced Overexpression of TGFβ and PODXL Contributes to Colorectal Cancer Cell Radioresistance through Enhanced Motility.
    Lee H; Kong JS; Lee SS; Kim A
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas.
    Heby M; Karnevi E; Elebro J; Nodin B; Eberhard J; Saukkonen K; Hagström J; Mustonen H; Seppänen H; Haglund C; Jirström K; Larsson AH
    Sci Rep; 2020 Jun; 10(1):10373. PubMed ID: 32587323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
    Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
    World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.
    Nodin B; Johannesson H; Wangefjord S; O'Connor DP; Lindquist KE; Uhlén M; Jirström K; Eberhard J
    Diagn Pathol; 2012 Aug; 7():115. PubMed ID: 22935204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.